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Diabetic mellitus confers a major risk of congenital
malformations, and is associated with diabetic embryopathy,
affecting multiple organs including the kidney. The DNA
paired box-2 (Pax-2) gene is essential in nephrogenesis.
We investigated whether high glucose alters Pax-2 gene
expression and aimed to delineate its underlying
mechanism(s) of action using both in vitro (mouse embryonic
mesenchymal epithelial cells (MK4) and ex vivo (kidney
explant from Hoxb7-green florescent protein (GFP) mice)
approaches. Pax-2 gene expression was determined by
reverse transcriptase-polymerase chain reaction, Western
blotting, and immunofluorescent staining. A fusion gene
containing the full-length 50-flanking region of the human
Pax-2 promoter linked to a luciferase reporter gene, pGL-2/
hPax-2, was transfected into MK4 cells with or without
dominant negative IjBa (DN IjBa) cotransfection. Fusion
gene expression level was quantified by cellular luciferase
activity. Reactive oxygen species (ROS) generation was
measured by lucigenin assay. Embryonic kidneys from
Hoxb7-GFP mice were cultured ex vivo. High D(þ ) glucose
(25 mM), compared to normal glucose (5 mM), specifically
induced Pax-2 gene expression in MK4 cells and kidney
explants. High glucose-induced Pax-2 gene expression is
mediated, at least in part, via ROS generation and activation
of the nuclear factor kappa B signaling pathway, but not via
protein kinase C, p38 mitogen-activated protein kinase
(MAPK), and p44/42 MAPK signaling.
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Diabetic mellitus confers a major risk factor for congenital
malformations. When the fetus is exposed to sustained high
ambient glucose, widespread fetal damage may affect multi-
ple organs including kidney (diabetic embryopathy).1,2
Infants born to women with pre-gestational insulin-depen-
dent diabetes mellitus have a 10-fold relative risk of
congenital malformations, and those born to women with
gestational diabetes have a 5-fold relative risk. Both the
diabetic mother and her fetus are at risk for significant
morbidity and mortality, even in the 21st century.3,4
Renal malformations account for approximately 40%
of childhood renal failure.5,6 During kidney development,
two major events, ureteric bud (UB) branching and mesen-
chymal-to-epithelial transformation control the main thrust
of renal morphogenesis. When the normal pattern of
nephrogenesis is interrupted, kidney abnormalities, such as
renal agenesis, renal dysplasia, or aplasia, may ensue.6–8
Kanwar et al.9 recently reviewed the mechanisms that
appear to be involved in diabetic embryopathy, pointing out
that high glucose increases damage to DNA and the
extracellular matrix via reactive oxygen species (ROS); high
glucose inhibits cyclooxygenase-2, resulting in prostaglandin
E2 deficiency; and high glucose may induce transcription
factors and proto-oncogenes. Kanwar et al.9 also demon-
strated that renal-specific oxidoreductase is closely linked to
renal morphogenesis in a high glucose milieu.10 However, the
molecular mechanisms by which high ambient glucose levels
lead to renal dysmorphogenesis and birth defects have not yet
been delineated.9–11
ROS have been proposed as a major factor in the
pathogenesis of diabetic nephropathy.12,13 Increased ROS
generation by high glucose directly damages DNA and also
alters the expression of extracellular matrix glycopro-
teins.14–16 Additionally, kidney-related key proto-oncogenes
and transcription factors such as glial cell-derived neuro-
trophic factor, cRet, and paired-box 2 (Pax-2) may be altered
in diabetic embryopathy,9 although clear experimental
evidence is presently lacking. The Pax-2 gene is a ‘kidney-
specific’ master gene that is expressed in both UB and
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mesenchymal cell lineages, normally optimizing UB branch-
ing and mesenchymal-to-epithelial transformation in kidney
development.17–19 Mutations in the Pax-2 gene cause
increased apoptosis,20–22 associated with renal hypopla-
sia.20,23,24 For instance, homozygous null Pax-2 mice fail to
form any kidneys, ureters, and genital tracts.25 In humans
and mice, heterozygous Pax-2 mutations cause kidney, eye,
and central nervous system abnormalities, constituting a
syndrome called renal-coloboma syndrome.26,27 The me-
chanism by which reduced Pax-2 expression leads to
decreased UB branching and subsequently to a reduced
number of nephrons in patients with renal-coloboma
syndrome seem to be highly related UB lineage apoptosis.28
It appears that regulation of UB cell survival by activation of
Pax-2-regulated factors such as Naip (neuronal apoptosis
inhibitory protein) and Wnt-4 will be powerful determinants
of congenital nephron endowment.28–31
The transcription factor nuclear factor kappa B (NF-kB) is
a major intracellular target in hyperglycemia and oxidative
stress.32,33 NF-kB plays a critical role in mediating immune
and inflammatory responses and apoptosis. It is also
associated with a number of chronic diseases including
diabetes and atherosclerosis.34,35
In the present study, we investigated whether there is a
link between hyperglycemia and Pax-2 gene expression that
might influence kidney development. We employed in vitro
and ex vivo approaches and observed that high glucose
(25 mM D-glucose) as compared to normal glucose (5 mM
D-glucose) specifically induced Pax-2 gene expression in
mouse embryonic mesenchymal epithelial cells (MK4) cells
and kidney explants, with ROS generation and the NF-kB
pathway certainly being involved as underlying mechanisms.
RESULTS
High glucose stimulates Pax-2 expression in MK4 cells
MK4 cells were incubated in media containing 1% depleted
fetal bovine serum (dFBS) and 25 mM different glucose
analogs such as D-glucose, D-mannitol, L-glucose, or 2-deoxy-
D-glucose. After incubation for 24 h, cells were harvested and
analyzed for Pax-2 messenger RNA (mRNA), reverse
transcriptase-polymerase chain reaction (RT-PCR), and
protein (Western blotting) levels. As shown in Figure 1, high
glucose stimulated the Pax-2 mRNA expression (Figure 1a,
RT-PCR) and protein (Figure 1b: Western blotting) in a
dose-dependent manner from 5 to 25 mM with a maximal
effect at 25 mM D-glucose. To maintain constant isotonicity or
osmolality, 5-mM glucose media was supplemented with
D-mannitol (20 mM) (final concentration) in additional
studies. Figure 2 indicates that high glucose as compared to
normal glucose specifically induced Pax-2 gene expression,
whereas other glucose analogs such as D-mannitol, L-glucose,
or 2-deoxy-D-glucose in MK4 cells had no effect, suggesting
that the effect of high D(þ )-glucose medium is specific
(Figure 2a: RT-PCR; Figure 2b: Western Blot). Moreover,
Pax-2 immunostaining with intranuclear appearance was
induced by high glucose, consistent with the fact that Pax-2 is
a nuclear transcription factor (Figure 3).36–38 Pax-2 expres-
sion was normalized by b-actin. The 24-h incubation period
was used for all subsequent studies.
p38 MAPK, p44/42 MEK, and PKC inhibitors fail to block the
high glucose effect on Pax-2 gene expression in MK4 cells
Figure 4a and b reveal that inhibitors of p38 mitogen-
activated protein kinase (MAPK) (SB203580), P44/42 MEK
(PD98059), and protein kinase C (PKC) (GF109203) could
not block the stimulatory effect of high glucose on Pax-2
mRNA and protein expression in MK4 cells, suggesting that
p38 MAPK, p44/42 MEK, and PKC signaling are not involved
in mediating the stimulatory influence of high glucose on
Pax-2 gene expression.
ROS generation and Pax-2 gene expression in MK4 cells
We observed that MK4 cells after 15 min incubation in high
glucose medium, ROS generation began to increase in MK4
cells, and this elevation lasted 60 min (Figure 5a). These data
indicate that high glucose induced ROS generation in MK4
cells. In order to confirm that ROS directly regulate Pax-2
gene expression, we performed studies involving the xanthine
oxidase (XO) system. Superoxide generated from the XO
system directly stimulates Pax-2 gene expression in MK4 cells
in a dose-dependent manner (Figure 5c, d, and e).
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Figure 1 | High glucose dose-dependent effect. High D(þ ) glucose
upregulates Pax-2 gene expression in a dose-dependent manner
in MK4 cells analyzed by (a) RT-PCR and (b) Western blot. After
synchronized with serum free medium overnight, the quiescent cells
were incubated in DMEM with 1% dFBS containing final glucose
concentration from 5 mM to 25 mM for 24 h, whereas D-mannitol was
supplemented to maintain constant isotonicity or osmolality;
(c) relative densities of Pax-2 were normalized to b-actin. The
normalized Pax-2 level in cells incubated in 5 mM glucose was
considered to be the control (100%). Each point represents the
mean7s.d. of three independent experiments. *Pp0.05; **Pp0.01;
***Pp0.005.
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Inhibitors of nicotinamide adenine dinucleotide phosphate
hydrogenase oxidase, mitochondrial electron transport chain
complex I, and NF-jB pathway block the stimulatory effect of
high glucose on Pax-2 gene expression in MK4 Cell
The stimulatory effect of high glucose on ROS generation was
inhibited in the presence of diphenylene iodonium chloride
(DPI) and rotenone, but not pyrrolidinedithiocarbamate
(PDTC) (Figure 5b). Figure 6 shows that inhibitors of
nicotinamide adenine dinucleotide phosphate hydrogenase
oxidase (DPI), mitochondrial electron transport chain
complex I (rotenone), and NF-kB pathway PDTC block the
stimulatory action of high glucose on Pax-2 expression in
MK4 cells. These data suggest that the stimulatory effect of
high glucose on Pax-2 gene expression is mediated via ROS
generation and the activation of NF-kB signaling pathway in
MK4 cells.
High glucose effect on Pax-2 gene expression in kidney
explants from Hoxb7-GFP mice
In order to confirm our in vitro observation, we adapted an
ex vivo model using embryonic kidney explants. Embryonic
kidneys at E16 gestation from Hoxb7-green florescent protein
(GFP) mice were isolated and cultured ex vivo as shown in
Figure 7a. After culturing the explants for 24 h in either
normal glucose (5 mM) or high glucose (25 mM) Dulbecco’s
modified Eagle’s medium (DMEM) with or without ROS
inhibitors, high glucose stimulated Pax-2 mRNA and
protein expression. The high glucose effect was blocked
by ROS inhibitors, as illustrated in Figure 7b and c. We have
also tested H2O2, an important source of O2
K
, and observed
that exogenous H2O2 at 10
5
M stimulates Pax-2 gene
expression modestly; however, in combination with high
glucose, the H2O2 stimulatory effect is enhanced substantially
as shown in Figure 7e (quantitative RT-PCR) and 7f
(Western blot).
High glucose effect on Pax-2 gene promoter activity
Transient transfection of pGL-2/hPax-2 in MK4 cells followed
by culturing in high glucose medium stimulated Pax-2 gene
promoter activity, compared to culturing the cells in normal
glucose medium. The stimulatory effect of high glucose was
inhibited in the presence of inhibitors of ROS and NF-kB
signaling pathway (Figure 8a). Moreover, after cotransfection
with pcDNA3.1/DN IkBa, high glucose-induced Pax-2
promoter activity was abolished, which suggests that NF-kB
is involved in Pax-2 transcription stimulated by high glucose
(Figure 8b). These data demonstrate that the stimulatory
effect of high glucose on Pax-2 gene expression occurs at the
transcriptional level via ROS activation of the NF-kB
signaling pathway.
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Figure 3 | Pax-2 immunofluorescence staining. High glucose
upregulates Pax-2 expression in MK4 cells as shown by
(a) immunofluorescence staining (original magnification  400).
Quiescent cells were incubated in either 5 mM or 25 mM D-glucose
DMEM containing 1% dFBS for 24 h; (b) The normalized Pax-2
level in cells incubated in 5 mM glucose was considered the
control (100%). Each point represents the mean 7s.d. of three
independent experiments. *Pp0.05; **Pp0.01; ***Pp0.005.
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Figure 2 | High glucose specifical effect. Pax-2 gene expression is
specifically stimulated by high D(þ ) glucose (25 mM), not by other
glucose analogs such as L-glucose, D(þ )-Mannitol, or 2-deoxy-D-
glucose in MK4 cells analyzed by (a) RT-PCR and (b) Western blot. The
quiescent cells were incubated in DMEM with 1% dFBS containing
different glucose analogs in 25 mM as final concentration for 24 h;
(c) the relative densities of Pax-2 were normalized to b-actin. The
normalized Pax-2 level in cells incubated in 5 mM glucose was
considered the control (100%). Each point represents the mean
7s.d. of three independent experiments. *Pp0.05; **Pp0.01;
***Pp0.005.
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DISCUSSION
The present studies demonstrate that high glucose stimulates
Pax-2 gene expression in mouse embryonic metanephric
mesenchymal cells and embryonic kidney explants. The
stimulatory effect of high glucose on Pax-2 gene expression is
mediated, at least in part, via ROS generation and activation
of NF-kB signaling pathway.
During embryogenesis, embryonic stem cells must pro-
liferate dynamically and precisely in order to form functional
organs. Additionally, apoptosis and proliferation is involved.
Any interruption or error caused by the surrounding
environment or misleading signals involved in gene regula-
tion can elicit aberrant organogenesis and may even be lethal.
For example, in renal morphogenesis, certain undifferen-
tiated metanephric mesenchyme must undergo apoptosis to
make room for UB branching.7,8 Diabetes constitutes an
adverse in utero environment that may impair nephrogenesis.
For example, a high glucose milieu can result in an abnormal
pattern of UB branching evoking duplex ureters or cystic
kidneys; reduced populations of nascent nephrons, resulting
in hypoplasia; increased apoptosis in mesenchyme and UB
epithelium, resulting in renal agenesis, aplasia, or dyspla-
sia.39–42 Nielsen et al.43 reported that the prevalence of renal
malformations such as renal agenesis and congenital
abnormalities of kidney and urinary tract have a strong
association with pre-gestational maternal diabetes, more than
cardiovascular congenital abnormalities or multiple conge-
nital abnormalities.
Renal-specific genes are also clearly important for accurate
nephrogenesis. The ‘kidney-specific’ master gene Pax-2 is
necessary for initial signaling of the Wolffian duct to optimize
UB branching and mesenchymal-to-epithelial transforma-
tion.19,26 Pax-2-null mice fail to form any kidneys, ureters,
and genital tracts.25 In humans and mice, heterozygous Pax-2
mutations cause kidney, eye, and central nervous system
abnormalities, constituting a syndrome called renal-colobo-
ma syndrome.26,27
To the best of our knowledge, high ambient glucose has
not been reported previously to regulate Pax-2 gene
expression and its underlying mechanism(s) of action in
embryonic kidney cells. In the present study, we employed
both in vitro (MK4 cells) and ex vivo (kidney explants)
approaches to explore this potential interaction. As our data
indicate, high D(þ ) glucose (25 mM) specifically and dose
dependently stimulated Pax-2 gene expression in MK4 cells,
whereas other glucose analogs such as D-mannitol, L-glucose,
and 2-deoxy-D-glucose had no effect. A similar stimulatory
action of high glucose was also observed in our kidney
explant system. Additionally, high glucose ambience increases
ROS generation in MK4 cells, and this was blocked by ROS
inhibitors, not by NF-kB inhibitors. These data are consistent
with our previous observation that high glucose induces ROS
generation in immortalized renal proximal tubular cells.44,45
In order to confirm that ROS directly regulate Pax-2 gene
expression, we examined the effect of the XO system. Indeed,
superoxide generated from the XO system directly stimulates
Pax-2 gene expression in MK4 cells in dose-dependent
manner; another important source of O2
K
, H2O2 at 10
5
M
stimulates Pax-2 gene expression modestly; however, in
combination with high glucose, the H2O2 stimulatory effect
is enhanced substantially in E16 kidney explants.
Brownlee12,13 has suggested that the underlying mechan-
isms regarding high glucose as an inducer of kidney damage,
indicating that excessive ROS generation and then subse-
quent PKC and NF-kB activation are the key elements in
tissue injury. Other studies have revealed that both p38
MAPK and p44/42 MAPK signaling pathways may also be
involved in hyperglycemia-induced ROS generation in
proximal tubular cells44,45 and mesangial cells.46,47 To
determine whether p38 MAPK, p44/42 MAPK, and PKC
signaling is involved in mediating the high glucose effect on
Pax-2 gene expression, inhibitors of these signaling pathways
were tested. Our data disclosed that SB203580, PD98059, or
GFX could not block the high glucose action on Pax-2 gene
expressions at both protein and mRNA levels, suggesting that
p38 MAPK, p44/42 MAPK, and PKC signaling pathways are
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Figure 4 | p38 MAPK, p44/42 MAPK, and PKC inhibitor effect.
Effect of SB203580, PD98059, and GFX on Pax-2 gene expression
stimulated by high glucose in MK4 cells as analyzed by (a) RT-PCR
and (b) Western blot; Quiescent cells were incubated in either 5 mM
or 25 mM D-glucose DMEM containing 1% dFBS for 24 h with or
without inhibitors; (c) the relative densities of the Pax-2 were
normalized to the b-actin. The normalized Pax-2 level in cells
incubated in 5 mM glucose was considered as the control (100%).
Each point represents the mean 7s.d. of three independent
experiments. *Pp0.05; **Pp0.01; ***Pp0.005.
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not involved. In contrast, we observed that the stimulatory
effect of high glucose on Pax-2 gene expression was blocked
in the presence of DPI, rotenone, and PDTC in both in vitro
and ex vivo studies, indicating that high glucose on Pax-2
gene expression is mediated, at least in part, via ROS
generation and activation of the NF-kB signaling pathway.
NF-kB is one of the major intracellular targets of
hyperglycemia.13,35 It is present in the cytoplasm as an
inactive heterodimer, consisting of the p50 and p65 subunits
complexed with IkB and it is activated through a common
pathway, which involves the phosphorylation-induced pro-
teasome-mediated degradation of the inhibitory subunit,
IkB. Upon stimulation, a serine kinase cascade is activated
leading to the phosphorylation of IkB and dissociating from
the NF-kB heterodimer. This event primes IkB as a substrate
for ubiquitination and subsequent degradation in the
cytoplasm. The NF-kB heterodimer is then translocated to
the nucleus and regulates the expression of a large number of
genes including growth factors (e.g., vascular endothelial
growth factor), pro-inflammatory cytokines (e.g., tumor
necrosis factor-a and interleukin-1b), receptor for advanced
glycation end products, adhesion molecules (e.g., vascular
cell adhesion molecule-1).34,35 The enzyme that phosphor-
ylates IkB is IkB kinase (IKK), a heterotrimeric complex
consisting of two catalytic subunits, IKKa (also called IKK1),
and IKKb (also called IKK2), and a regulatory subunit,
IKKg.48,49 In order to further understand the underlying
mechanisms of the NF-kB pathway involved in high glucose
induced Pax-2 gene expression, we tested DN IkBa which can
bind the p50 and p65 subunits complexed in an inactive
form, preventing p50 and p65 from translocating to the
nucleus. Our data in MK4 cells demonstrate that high glucose
stimulates Pax-2 promoter activity at a transcriptional level,
which may be blocked by both ROS and NF-kB inhibitors.
After cotransfection with DN IkBa, Pax-2 promoter activity
induced by high glucose is abolished, suggesting that NF-kB
is involved in glucose-induced stimulation of Pax-2 tran-
scription. Using the sequence searching software AliBaba2.1
(www.gene-regulation.com), we have now identified several
NF-kB binding motifs including six of GGrmwkyCCC and
two of GGGGmyTyy located in a full length of 50-promoter
region of Pax-2 (AF515729). Additional studies are ongoing
to address the underlying molecular mechanisms.
Taken together, these data demonstrate that the stimula-
tory effect of high glucose on Pax-2 gene expression is
mediated, at least in part, via ROS generation and activation
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Figure 5 | High glucose induced ROS on Pax-2 gene expression. High glucose time dependently stimulates ROS generation in (a) MK4 cells ,
that is blocked by ROS inhibitors, but not (b) NF-kB inhibitors analyzed by lucigenin assay. Moreover, superoxide generated from XO system
(c) directly stimulates Pax-2 gene expression in MK4 cells in a dose-dependent manner, shown here as analyzed by (d) real-time PCR and
(e) Western blot; (a) Quiescent cells were incubated in either 5 mM glucose DMEM or 25 mM containing 1% dFBS for periods of 15 min to
2 h, then trypsinized and assayed. The final value of ROS generation was normalized by the protein concentration of sample. At the 15-min
incubation point, basal ROS generation was, RLU/ug/ul: 1817784.35 vs 2250.85790.40 in 5 mM and 25 mM glucose medium, respectively;
(b) quiescent cells were incubated in either 5 mM glucose DMEM or 25 mM containing 1% dFBS with or with inhibitors for periods of 30 min,
then trypsinized and assayed. The normalized ROS generation in cells incubated in 5 mM glucose was considered the control (100%);
(c) superoxide generated from the XO system was detected by lucigenin assay; (d, e) quiescent cells were incubated in 5 mm glucose
DMEM containing 1% dFBS with or with XO system for 24 h. Each point represents the mean 7s.d. of three independent experiments.
*Pp0.05; **Pp0.01; ***Pp0.005.
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of the NF-kB signaling pathway, but not via the PKC,
p38MAPK, and p44/42 MAPK signaling pathways. This
indicates that modifying these pathways might be important
in further understanding diabetic embryopathy.
MATERIALS AND METHODS
Reagents
Normal glucose (5 mM D-glucose DMEM (Cat. No. 12320) was
purchased from Invitrogen Inc. (Burlington, Ontario, Canada).
D(þ )-glucose, L-glucose, D-mannitol, 2-deoxy-D-glucose, DPI,
rotenone, GF109203X, PDTC, xanthineoxidase, and hypoxanthine
were purchased from Sigma-Aldrich Canada Ltd. (Oakville, ON,
Canada). SB203580, PD98059 were obtained from CalBiochem (San
Diego, CA, USA). Mouse anti-b-actin monoclonal antibody (clone
AC-15) and rabbit polyclonal anti-Pax-2 antibody were purchased
from Sigma-Aldrich Canada Ltd (Oakville, ON, Canada) and
Covance (Richmond, CA, USA), respectively. The luciferase activity
assay kit was purchased from Promega (Fisher Scientific, Montreal,
QC, Canada). Hoxb7-GFP mice were obtained from Dr Frank
Costatini (Department of Genetics and Development, Columbia
University Medical Center, New York, NY, USA),50,51 and the 4.2-kb
ApaI/NcoI fragment of the human PAX2 promoter (AF515729) was
a generous gift from Dr Michael Eccles (Department of Pathology,
University of Otago, Dunedin, New Zealand).20,52 MK4 cells were
from Dr S Steven Potter (Division of Developmental Biology,
Children’s Hospital Medical Center, Cincinnati, OH, USA).53
Dominant negative IkBa (DN IkBa) plasmid (pcDNA3.1/DN IkBa)
from Dr John SD Chan (CHUM-Hoˆtel-Dieu, Montreal, QC,
Canada), was produced by PCR-based site-directed mutagenesis in
Serines 32 and 36 in the N terminal regulatory domain of IkBa
(NM_010907) to resist phosphorylation. DN IkBa can bind the p50
and p65 subunits complexed in an inactive form, preventing p50
and p65 from translocating to the nucleus for further action.
dFBS, depleted of endogenous steroid and thyroid hormones was
prepared by incubation with 1% activated charcoal and 1% AG 1 8
ion-exchange resin (Bio-Rad Laboratories Inc., Richmond, CA,
USA) for 16–24 h at room temperature, as described previously.36,37
Although endogenous steroid and thyroid hormones have been
removed from FBS, the purpose of adding 1% dFBS into either 5 mM
glucose or 25 mm DMEM after rendering them quiescent with
serum free medium is to support the cells during the additional
24 h experimental period until harvested, as demonstrated pre-
viously.36,37
Culture of MK4 cells
The MK4 cell line is representative of late embryonic metanephric
mesenchyme as it undergoes mesenchymal to epithelial conver-
sion.53 MK4 cells are relatively polygonal or epithelial in shape and
express genes typical of late mesenchyme, including Pax-2, Pax-8,
Wnt-4, Cadherin-6, Collagen IV, and LFB3 (REF).53 In the present
study, MK4 cells were cultured in normal glucose DMEM (pH 7.45),
supplemented with 5% FBS, 100 U/ml of penicillin, and 100 mg/ml
of streptomycin in 95% air and 5% CO2 at 371C.
Ex vivo embryonic kidney culture
Embryonic kidneys were isolated from timed pregnant Hoxb7-GFP
mice at embryonic stage E1650,51 under sterile conditions and
cultured either in normal glucose or high glucose DMEM supplied
with 1% dFBS. These mice specifically express the GFP in the UB
driven by the Hoxb7 promoter. Each kidney explant was cultured in
1 ml of medium in a separate well of a 24-well plate for up to 24 h in
the presence or absence of DPI (106 M), rotenone (106 M), and
H2O2 (10
5
M).
Immunofluorescence studies
MK4 cells were grown to 70–80% confluence in two-chamber slides,
and then synchronized with overnight serum-free medium. After
culture in either normal glucose or high glucose DMEM for 24 h,
cells were processed for immunofluorescence investigation as
reported previously.36,37 Immunofluorescence images were recorded
with a Olympus 1 71 Microscope (CARSEN, ON, Canada). The
images are presented at  400 original magnification.
Western blotting
Western blots were performed as in previous studies.36,37 Briefly,
small aliquots (20–50 ml) of homogenized cell sample were subjected
to 10% sodiumdodecylsulfate-polyacrylamide gel electrophoresis
and then transferred onto a polyvinylidene difluoride membrane
(Hybond-P, Amersham Pharmacia Biotech, Canada). The mem-
brane was first blotted for anti-Pax-2 and then re-blotted for b-actin.
The relative densities of the Pax-2 vs b-actin bands were measured
by computerized laser densitometry.
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Figure 6 | Inhibitory effect of ROS and NF-jB inhibitors. The
inhibitory effect of PDTC, DPI, and rotenone on Pax-2 gene
expression upregulated by high glucose in MK4 cells analyzed
by (a) RT-PCR and (b) Western blot; quiescent cells were incubated in
either 5 mM or 25 mM D-glucose DMEM containing 1% dFBS for 24 h
with or without inhibitors; (c) the relative densities of Pax-2 were
compared with b-actin. The normalized Pax-2 level in cells incubated
in 5 mM glucose was considered the control (100%). Each point
represents the mean 7s.d. of three independent experiments.
*Pp0.05; **Pp0.01; ***Pp0.005.
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ROS generation
ROS production was quantified by the lucigenin method.44,45 After
overnight culture in serum-free medium to render them quiescent,
cells were incubated in either normal glucose or high glucose
DMEM containing 1% depleted FBS for periods of 15 min to 2 h.
Cells were then trypsinized, collected by centrifugation, and the
pellet washed in modified Krebs buffer containing NaCl (130 mM),
KCl (5 mM), MgCl2 (1 mM), CaCl2 (1.5 mM), K2HPO4 (1 mM), and
N-2-hydroxyethylpiperazine-N0-2-ethane sulfonic acid (20 mM), pH
7.4. After washing, the cells were resuspended in Krebs buffer with
1 mg/ml bovine serum albumin, and cell concentration was adjusted
to 1 107 in 900ml buffer. To measure ROS production, the cell
suspension was transferred to plastic tubes and assessed in a
luminometer (LB 9507, Berthold, Wildbad, Germany). The final
value, RLU (related light unit) of ROS generation was normalized by
protein concentration of the samples.
RT-PCR for Pax-2 mRNA
Total RNA was prepared from cultured cells according to the
manufacturer’s protocol using TRIZOL (Invitrogen Inc.).36,37 First
strand cDNA was synthesized with the Super-Script preamplification
system (Invitrogen Inc.). We employed the following forward and
reverse primers: forward primer 50-TTT GTG AAC GGC CGG CCC
CTA-30, and the reverse primer 50-CAT TGT CAC AGA TGC CCT
CGG-30; these correspond to the nucleotide sequences Nþ 622 to
Nþ 642 and Nþ 902 to Nþ 922 of Pax-2 cDNA.36,37 For internal
control, we deployed primers specific for mouse b-actin54 (forward
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Figure 7 | High glucose effect on Pax-2 gene expression ex vivo. Ex vivo study. Kidney explant isolated from Hoxb7-GFP mice on
embryonic day 16 (a); the inhibitory effect of DPI and rotenone on Pax-2 gene expression was upregulated by high glucose in renal
explant analyzed by (b) RT-PCR and (c) Western blot, respectively; (d) the relative densities of Pax-2 were compared with b-actin. The
normalized Pax-2 level in cells incubated in 5 mM glucose was considered the control (100%); H2O2 effect on Pax-2 gene expression analyzed
by (e) quantitative RT-PCR, and (f) Western blot, respectively. Each point represents the mean7s.d. of three independent experiments.
*Pp0.05; **Pp0.01; ***Pp0.005.
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and reverse primers 50-ATG CCA TCC TGC GTC TGG ACC TGG
C-30 and 50-AGC ATT TGC GGT GCA CGA TGG AGG G-30,
corresponding to nucleotide sequences Nþ 600 to Nþ 622 and
Nþ 1179 to Nþ 1203 of mouse b-actin cDNA (X03672)).
Real-time-PCR (quantitative RT-PCR)
Quantitative RT-PCR were performed as in previous studies.36 In
brief, first-strand cDNA was produced from 2 mg of random
hexamer primed total RNA using Super-Script pre-amplification
system (Invitrogen). Relative quantitation by real-time PCR was
carried out using iQTM SYBR@ Green Supermix Kit (Bio-Rad
Laboratories, Mississauga, ON, Canada) and MiniOpticonTM Real-
Time PCR Detection System (Bio-Rad), following the protocol
described by the supplier. PCR reactions in triplicate underwent 40
cycles of 951C for 20 s, 601C for 20 s, 721C for 20 s, and 791C for 5 s
in the thermal cycler. The parameter threshold cycle value was
measured to determine starting copy number of target genes using
the standard curve. Lower value of threshold cycle indicates higher
amount of PCR products. We employed the following forward and
reverse primers for Pax-2: forward primer 50-ACA TCA AAT CAG
AAC AGG GGA AC-30, and the reverse primer 50-CAT GTC ACG
ACC AGT CAC AAC-30; these correspond to the nucleotide
sequences Nþ 1319 to Nþ 1341 and Nþ 1453 to Nþ 1473 of
Pax-2 cDNA (NM_003990). For internal control, we deployed
primers specific for mouse b-actin (forward and reverse primers
50-CGT GCG TGA CAT CAA AGA GAA-30 and 50-GCT CGT TGC
CAA TAG TGA TGA-30, corresponding to nucleotide sequences
Nþ 704 to Nþ 724 and Nþ 820 to Nþ 840 of mouse b-actin
cDNA [NM_007393]).36
Luciferase assay for high glucose effect on Pax-2 gene
promoter activity
We have constructed a fusion gene, pGL-2/hPax-2, containing a full
length 50-promoter of 4.2 kb ApaI/NcoI fragment of the human
PAX2 promoter (AF515729)20,52 inserted into luciferase reporter
pGL-2 basic vector (Promega), and performed transient transfection
of this fusion gene into MK4 cells by Lipofectamine 2000
(Invitrogen Inc.), whereas pGL-2 basic vector serving as control.
IkBa is an inhibitor of NF-kB. To study the effect of DN IkBa on
high glucose induced Pax-2 promoter activity, we transiently
cotransfected both plasmids: pGL-2/hPax-2 and pcDNA3.1/DN
IkBa, into MK4 cells, whereas both pGL-2 and pcDNA3.1 basic
vector served as controls. MK4 cells grown in 12-well plates were
transfected with 1.5 mg of each plasmid. After a 24 h stimulation
with high glucose medium with or without ROS inhibitors, cells
were harvested and the luciferase activity was quantified by
Luciferase assay kit (Promega) according to the protocol from the
supplier with renilla luciferase as an internal control.
Statistical analysis
Statistical significance between experimental groups was analyzed
initially by student’s t-test or by one-way analysis of variance
followed by the Bonferroni test as appropriate. Three to four
separate experiments were performed for each protocol. Data are
expressed as means 7s.d. A probability level of Pp0.05 was
considered statistically significant.
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Figure 8 | High glucose effect on the full length of 50-franking
region of Pax-2 promoter activity in MK4 cells. (a) MK4 cells grown
in 12-well plates were transiently transfected with 1.5 mg of pGL-2/
hPax-2 plasmid by Lipofectamine 2000, with pGL-2 basic vector
serving as control; DN IKBa effect on high glucose induced Pax-2
promoter activity. (b) MK4 cells were transiently cotransfected with
1.5mg of each pGL-2/hPax-2 and pcDNA3.1/DNIKBa plasmid by
Lipofectamine 2000, whereas pcDNA3.1 plasmid serving as the
control. Promoter activity was measured by luciferase assay kit with
renilla luciferase as an internal control after 24 h stimulation by high
glucose with or without inhibitors. The final value of Pax-2 promoter
activity was normalized by the protein concentration of sample.
Normalized Pax-2 promoter activity in cells incubated in 5 mM glucose
was considered the control (100%). Each point represents the mean
7s.d. of three independent experiments. *Pp0.05; **Pp0.01;
***Pp0.005.
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